Addex Therapeutics Issues 93 Million Shares to Create Treasury Stock
The 93 million registered shares, with a nominal value of CHF 0.01 each, were subscribed by the company’s wholly owned subsidiary. Issued share capital rises to CHF 3,116,544.96, while outstanding shares remain unchanged.